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Abstract
This thesis explores various methods for analyzing data generated using the next-
generation sequencing technology, RNA-Seq. Two methods are developed which at-
tempt to accurately calculate RNA expression, the first using a penalized regression
approach to remove bias based on nucleotide composition, as well as a second which
demonstrates the use of variation as an estimate of gene expression. Another method
is developed which utilizes RNA-Seq gene expression data to identify genomic regu-
latory elements using a semi-parametric model with multiple responses considered si-
multaneously. Lastly, a method is established which identifies differentially expressed
genes in timecourse data using a functional ANOVA mixed-effect model.
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Chapter 1
Introduction
1.1 RNA-Seq Short-Read Data
The central dogma of molecular biology, stated in Crick et al. (1970), explains each of
the possible avenues for information transfer in biological systems. Specifically it de-
scribes the ways in which information flows between the three major macromolecules
which are essential for life: deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and
finally proteins. Figure 1.1 outlines five of these nine possible information transfers.
Transfers from DNA to DNA, DNA to RNA, and RNA to protein are considered the
group of general transfers. These general transfers are referred to as DNA replication,
transcription and translation respectively. The special transfer of RNA to DNA is
called reverse transcription and is an important step in the creation of data in this
work.
Many of the methods developed in this thesis are centered around the biological
process of gene expression which is shown in Figure 1.2. The most basic definition
of gene expression is used to attribute a particular phenotype to a particular geno-
type. The genotype is defined by the genome of an organism which is encoded using
DNA. DNA, deoxyribonucleic acid, is composed of four nucleotides adenine, cytosine,
thymine, and guanine. These are notated using A, C, T and G. DNA is composed
of two strands of these nucleotides arranged in a double helix. The nucleotides, also
called base pairs, are connected between the two strands according to pairing rules,
specifically, A goes with T and C goes with G, so the information of the genome is
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Figure 1.1: The central dogma of biology. The central dogma of biology, from
Crick et al. (1970) establishes the possible information transfers in biology. Shown
here are the general transfers; DNA replication (DNA to DNA), transcription (DNA
to RNA), and translation (RNA to protein). Also shown are two special trans-
fers; reverse transcription (RNA to DNA) and RNA replication (RNA to RNA).
Reverse transcription plays an important role the next-generation sequencing tech-
nology RNA-Seq.
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Figure 1.2: Gene expression. Gene expression shown via both transcription to
RNA as well as translation to protein.
known through a single strand. Specific sections of the genome, various lengths of
sequences of A, C, T and G, are labeled genes. The term gene has many associated
definitions but for the purpose of this work a section of the genome which is used to
create a gene product will be labeled a gene. Gene product may be either RNA or
ultimately protein. Stretches of DNA sequences which are not considered genes are
sometimes called “junk DNA.” A more appropriate term is non-coding DNA. While
some DNA may truly serve no purpose, however this seems increasingly unlikely, some
non-coding DNA is currently known to serve a number of functions. One in particular
which will be discussed in Chapter 4 is regulation through the use of transcription
factor binding sites.
The genetic code which makes up the genotype determines the phenotype. Specif-
ically, genes are used to create RNA and then protein, which are both gene products.
The process of creating RNA or protein from the corresponding genes is called gene
expression. The process of creating RNA copies from the DNA of a gene is referred to
as transcription. Transcription takes place in a cell nucleus using RNA polymerase.
The RNA polymerase reads the DNA sequence one nucleotide at a time and simul-
taneously adds the corresponding RNA nucleotide to a newly created RNA strand.
While DNA uses the nucleotides adenine, cytosine, thymine, and guanine, RNA in-
stead uses guanine, adenine, uracil and cytosine which are notated using G, A, U and
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C. So DNA nucleotides A, C and G become RNA nucleotides A, C and G. The DNA
nucleotide T is replaced by an RNA nucleotide U.
The initial transcription step transfers all of the coding DNA of a particular gene
while nearby non-coding DNA such as promoters are left out. Before translation to
protein, eukaryotic organisms require a second RNA processing step called splicing,
which is shown in Figure 1.3. The product of the initial transcription is called pre-
mRNA which contains two distinct type of sequences, namely introns and exons. The
sequences labeled introns will be removed during splicing, while sequences labeled
exons are retained during splicing and join to create messenger RNA, mRNA. (The
definitions of intron and exon and based on their retention or removal during splicing.
While introns are removed before the creation of mRNA they are still believed to
have other biological functions.) Before splicing the RNA content may be called the
transcriptome, while after splicing it is referred to as the exome. The mRNA sequence
produced from the DNA of a particular gene may also be referred to as a gene to
indicate it came from a particular sequence of DNA.
The final gene product, protein, is created from mRNA via translation. Certain
exons of the final mRNA are considered part of the coding sequence and are used
for translation into protein. Others, at either end of the sequence are part of the
untranslated region. (This distinction can be used to label exons as coding and non-
coding.) The coding sequence of RNA nucleotides is considered in triplets called
condons such as UUU, UCA, GAC, and so on. Each codon is translated into a
particular amino acid, the combination of which makes up the final protein.
Quantifying gene expression is a common task in biology research. Researchers
would ultimately like to measure the final gene product, protein, but this is currently
a difficult task. The much easier and more common measurement is that of mRNA.
Numerous methods exist for measuring mRNA. RT-qPCR, or reverse transcription
quantitative polymerase chain reaction can be used to to measure the number of
4
Figure 1.3: From DNA to Protein. Details of the gene expression process including
the splicing step.
copies of known mRNA sequences. DNA microarrays can be used to simulataneously
measure the relative mRNA abundance of a number of known genes.
RNA-Seq is a high-throughput sequencing technology which is used to investi-
gate the RNA content of a sample by sequencing its cDNA. (Wang et al. (2009))
RNA-Seq is sometimes referred to as “next-generation sequencing” and is the current
successor to DNA microarrays for sequencing the entire transcriptome. Unlike mi-
croarrays, RNA-Seq can be used to provide nucleotide level information for the entire
transcriptome, thus making it a powerful tool for transcriptomics.
RNA-Seq data creation begins with gathering a sample of RNA which is then used
to produce a cDNA fragment library. This cDNA library is obtained through the use
of the previously mentioned reverse transcription which transfers information from
the RNA of the sample to cDNA. (cDNA, complementary DNA, is the name given
to DNA which has been synthesized from RNA using reverse transcription.) Each of
these cDNA fragments are then sequenced to obtain “short-reads.” A “short-read”
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refers to the nucleotide composition of the sequence. RNA molecules are composed
of four nucleotides: guanine, adenine, uracil and cytosine. These are notated using
G, A, U and C. However, since RNA-Seq uses reverse transcription, “short-reads” are
always written using the corresponding DNA nucleotides which are adenine, cytosine,
thymine, and guanine. These nucleotides are notated using A, C, T and G. (Often
reference will be made to base pairs (bp) which comes from the double-stranded nature
of DNA despite the single stranded nature of cDNA and mRNA.) For example, the
sequence AATGCTCGTTAGCTAGTCGATGGCC, is a “short-read” of length 25.
Frequently, RNA-Seq analysis focuses specifically on messenger RNA (mRNA) which
is used for translation into amino acids and thus the creation of protein. Several
methods exist for mRNA isolation of RNA samples. (Aranda IV et al. (2009))
Currently this sequencing is done using a number of sequencing technologies in-
cluding the Illumina Genome Analyzer IIx, Applied Biosystems SOLiD and Roche
454. Read length can vary from roughly 30-400 base pairs, before trimming based on
quality scores. After obtaining millions of short-reads from sequencing, these reads
are mapped (or “aligned”) to a reference genome or reference transcripts. (Or used
to obtain a de novo assembly, which will not be considered in this text but is a con-
siderable advantage over the previous microarray technology.) A number of software
packages exist for read mapping, including Bowtie, SeqMap, Short Oligonucleotide
Analysis Package (SOAP), and CLC Genomics. Once the reads have been mapped,
relative abundance can be used to determine RNA gene expression levels. The most
commonly used method of quantifying gene expression, RPKM developed in Mor-
tazavi et al. (2008), is used to correct for two well known biases. RPKM, or reads
per kilobase per million mapped reads, is the number of reads mapping to a partic-
ular gene, normalized both by the length of the gene, as well as the total number of
mapped reads over the entire genome. Correcting for the length of gene and total
mapped reads allows for comparison between genes within an experiment, as well as
6
comparison of the same gene between experiments, respectively.
Figure 1.4 details the data creation process, which is necessary before embarking
on statistical analysis. Again, using a sample of RNA, short-reads are obtained. At
this point there are essentially two steps remaining before statistical analysis, mapping
and storing the data for analysis.
For the majority of the following chapters, the data has been mapped to the
reference using the alignment tool Bowtie. (Langmead et al. (2009)) At the most
basic level, each short-read is compared with each possible position on the genome
and checked for matching nucleotide composition. (The actual algorithms used in
practice are much more efficient.) More specifically, there are a number of options
for how we determine the alignments. An alignment is a combination of a short-read
(sequence of A, C, T and G) and a position on the reference genome. (Where each
nucleotide of the read matches the reference.)
First, there are a number of options determining what is a valid alignment. It
is possible to define a valid alignment as those where the read exactly matches the
reference. For practical reasons however, this is usually not the case. In practice
valid alignments maybe be allowed to contain a limited number of mismatches with
the reference. This will allow for reads with sequencing errors to still be mapped.
This also allows for alignment given the presence of genetic variation such as a single-
nucleotide polymorphism. There are a number of metrics for allowing mismatches,
all of which are detailed in the Bowtie documentation. (Frequently a small number of
mismatches, usually between one and five depending on the read length, are allowed,
as long as their combined quality scores do not exceed a predetermined threshold.
This would mean they are all rather unlikely to truly be mismatched.)
Second, it must be decided which alignments are reported. There are generally
a number of ways to do this, arising from the fact that with current read lengths,
there are frequently reads with multiple valid alignments. The default behavior of
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the Bowtie aligner is to simply output the first valid alignment for a read, and not
consider any further alignments. While this is by far the fastest method, it is not
frequently used. One method, after finding all possible valid alignments, simply
reports them all. (Methods for estimating gene expression which rely on this type of
data probabilistically assign the reads with multiple reported alignments.) Another
method only reports alignments with one valid alignment. A middle-ground between
reporting all valid alignments and uniquely aligning reads, would be to first find all
valid alignments, then report the best alignment based on quality scores. Each of
these methods are currently used in practice with the unique method seemingly the
most popular.
Once a list of reported alignments has been created, that data is converted into a
format which will be used for statistical analysis by summarizing the alignments at
each nucleotide. The bottom two images of Figure 1.4 illustrate two ways this may
be done. The first lists read counts at each nucleotide position determined by the
number of reads which begin at that particular position. The second, instead of only
considering the start positions, lists the number of reads that cover each position.
(Either of these can be used to obtain a simple count of the total number of reads
mapping to a gene which could then be used to calculate simple expression estimates
such as RPKM.) While both of these methods are used in practice, it is frequently
more beneficial to have data based on the starting position of the reads.
1.2 Chapter Descriptions
• Chapter 2: Bias Correction in RNA-Seq Short-Read Counts using Penalized
Regression includes work which appeared in Statistics in Biosciences in 2012
along with Ping Ma and Xuming He. A penalized regression approach is used
to remove bias in RNA-Seq short-read counts based on the information of the
8
Figure 1.4: RNA-Seq data creation process. An illustration of two ways to
conceptualize RNA-Seq data. Top Left: Physical samples are sequenced. Top Right:
Output of sequencing, a series of short-reads. Middle: The sequenced reads are
mapped to the genome. Here for example the example reads are mapped to two
example genes. Bottom Left: First data conceptualization. The mapped reads are
stored according to the start position of their mapping. Bottom Right: Second data
conceptualization. For each position, the number of reads which cover the position
are recorded. 9
surrounding nucleotides of a given read in a computationally efficient manner.
• Chapter 3: Gene Expression Quantification Using Transcript Reads Variation
includes work with Ping Ma which introduces a novel approach to estimating
gene expression levels based on a mixture of mean and variance rather than
only the mean of the read counts. Preliminary results were presented at the
2012 Joint Statistical Meetings.
• Chapter 4: Identification Of Regulatory Elements Using Next-Generation Se-
quencing Data is work with Wenxuan Zhong. We develop a method for identify-
ing regulatory elements using a semi-parametric model with multiple responses
considered simultaneously. Preliminary results were presented at the 2012 Al-
gorithms for Threat Detection Workshop.
• Chapter 5: Identifying Differentially Expressed Genes Using Timecourse RNA-
Seq Short-Read Count Data is work with Ping Ma to identify differentially
expressed genes using timecourse RNA-Seq read count data. The proposed
method uses a functional ANOVA mixed-effect model and a test is developed
based on the resulting Kullback-Leibler ratio.
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Chapter 2
Bias Correction in RNA-Seq
Short-Read Counts using Penalized
Regression
RNA-Seq produces tens of millions of short reads. When mapped to the genome
or reference transcripts, RNA-Seq data can be summarized by a very large number
of short-read counts. Accurate transcript quantification, such as gene expression
calculation, relies on proper correction of sequence bias in the RNA-Seq short-read
counts. We use a linear model for the sequence bias, which is much more flexible than
the popular Poisson model. We fit the model using a penalized regression method,
which allows for a significant dimension reduction. The algorithm is scalable for
modeling RNA-Seq data. We demonstrate the excellent performance of the proposed
method by applying it to real data examples. The methods are implemented in
open-source code, which is available in the R package lmbc.
2.1 Introduction
With the rapid development of second-generation sequencing technologies, RNA-Seq
has become a popular tool for transcriptome analysis (Mortazavi et al. (2008), Na-
galakshmi et al. (2008), Wilhelm et al. (2008)). It produces digital signals and offers
the chance to detect novel transcripts by obtaining tens of millions of short reads.
When mapped to the genome or reference transcripts, RNA-Seq data can be summa-
rized by a tremendous number of short-read counts. The huge number of short-read
counts enables researchers to make transcript quantification in ultra-high resolution.
A number of researchers have worked on transcript quantification, in particular,
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the gene expression calculation, using these short-read counts. Mortazavi et al. (2008)
develop a simple method, in which the expression level of a transcript is quantified
as reads per kilobase of the transcript per million mapped reads to the transcriptome
(RPKM). A variant, FPKM is developed in Trapnell et al. (2010). These analysis
methods assume, explicitly or implicitly, a naive constant-rate Poisson model, which
often fits the data poorly.
Recent work found that short-read counts have significant sequence bias, e.g., GC-
rich regions tend to have larger read counts than AT-rich regions, see Dohm et al.
(2008), which renders simple transcript quantification methods like RPKM invalid.
Thus, more elaborate statistical models that can effectively remove the sequence bias
of the short-read counts are highly desirable to make transcript quantification more
accurate. Li et al. (2010) and Bullard et al. (2010) developed Poisson regression
models with variable rates for modeling the short-read counts. However, the short-
read counts data are observed to be overdispersed, which renders the the Poisson
model inadequate. Moreover, Poisson model-fitting using the iterative re-weighted
least squares is computationally expensive with the large amount of data produced
by RNA-Seq. Because of the inadequate fit of the Poisson model, Li et al. (2010)
also attempted a regression tree model, MART (Friedman (2001), Friedman (2002)),
which provides a much better fit. However, the price paid is that as an algorithmic
approach, the MART model does not enjoy the nice interpretation of the Poisson
model and it is hard to make statistical inference based on the method.
To surmount these challenges, in this chapter we develop a model-based bias
correction approach, in which we linearly model the sequence bias of logarithm-
transformed read counts as a function of the surrounding dinucleotide configurations.
The linear model enjoys an easy interpretation and has many readily available infer-
ence tools. We fit the model using a distance weighted penalized regression method,
which enables effective dimension reduction. The LARS algorithm is employed for
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model-fitting, which provides efficient and fast computation. We demonstrate the ex-
cellent performance of our proposed method by applying it to real data examples. The
methods are implemented in open-source code, which is available in the R package
lmbc. Details can be found in the appendix.
2.2 Materials and Methods
2.2.1 Dinucleotide Linear Model
Let nij denote the counts of reads that are mapped to the genome starting at the jth
nucleotide of the ith gene, where i = 1, 2, . . . , G, j = 1, . . . , Li. As observed in Li et al.
(2010), the read counts in each nucleotide in the same gene are highly heterogeneous,
and highly correlated across tissues, which can be seen in Figure 2.1.
Figure 1 of Li et al. (2010) also suggests that the read counts in a nucleotide
might have bias associated with its genomic position, which can be determined by
the neighborhood nucleotides composition. Thus Li et al. (2010) considered associ-
ating the read counts with neighborhood single nucleotide composition by additive
models. In this paper, we develop a linear model relating the short read count at
a nucleotide with its neighborhood overlapping dinucleotide compositions, through
which the nucleotide interactions are naturally built in. We assume that the log
transformed count of reads, yij = log(nij + 1), depends on Ku nucleotide pairs imme-
diately upstream and Kd nucleotide pairs immediately downstream the read, denoted
as bij,−Ku , bij,−(Ku−1), . . . , bij,(Kd−1), bij,Kd , see Figure 2.2, through the following linear
model:
yij = α + vi +
Kd∑
k=−Ku
∑
h∈H
βkhI(bijk = h) + ij, (2.1)
where H = {CC,GG, TT,AC,CA,AG,GA,AT, TA,CG,GC,CT, TC,GT, TG}
13
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Figure 2.1: Counts of reads along gene Apoe in different tissues of the Wold
data. (a) Brain, (b) liver, (c) skeletal muscle.
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Figure 2.2: An illustration of the neighborhood overlapping dinucleotide
composition A read is mapped to the genome starting at position 0. Upstream
positions are labeled as negative and downstream positions are labeled as positive.
(AA was used as baseline), α is the grand mean, vi is the main effect of gene i, under
the constraint
∑
vi = 0, I(bij,k = h) equals 1 if the kth dinucleotide of the surrounding
sequence is h, and 0 otherwise, βkh is the coefficient of the effect of dinucleotide h
occurring in the kth position, and ij ∼ N(0, σ2). Let K = Ku +Kd. The constant 1
is added to the original counts to account for positions with zero reads mapped. This
linear model uses 15K +G parameters to model the sequence bias of read counts. It
is worth noting that the trinucleotide composition may be considered in the model,
but the large number of parameters, i.e, 63 parameters for each trinucleotide position,
incurs a rapid surge of the computation costs for model-fitting.
2.2.2 Model-fitting and the Distance-weighted Penalized
Regression
In practice, the number of upstream nucleotides Ku and Kd in model 2.1 need to be
specified. One way is to assign sufficiently large numbers to Ku and Kd so that the
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related dinucleotides are all included in the model. However, if we set Ku = 40 and
Kd = 40 (thus K = 80), we will have roughly 1200 dinucleotide coefficients βkh to
estimate. With such a huge number of coefficients, many of which are redundant,
the calculations are unstable and error-prone. To alleviate the computational cost
and to stabilize the algorithm, we use a penalized regression method to determine
the number of nucleotides adaptively. Since the number of overlapping dinucleotides
K corresponds to K single nucleotides, our penalized regression directly searches for
an optimal number of single nucleotides. Among penalized regression methods, the
L1 penalized likelihood procedure is very effective since the L1 penalty encourages
shrinkage of irrelevant predictors to be exactly zero. The standard L1 penalty uses
the same weights for different predictors. However, the predictors in our model are
dinucleotides, and it is observed in Li et al. (2010) that the impact of the nucleotides
on the modeling read counts becomes smaller as the nucleotides get further away
from the mapped reads. We thus consider a distance-weighted L1 penalty (Zhu &
Liu (2009)) in our algorithm so different nucleotides are penalized according to their
relative distance to the mapped reads.
Algorithm:
(1.) We first fit a single nucleotide model with distance-weighted penalty,
G∑
i=1
Li∑
j=1
{
yij − α− vi −
Kd∑
k=−Ku
∑
h∈H∗
β∗khI(b
∗
ijk = h)
}2
+ λ
Kd∑
k=−Ku
∑
h∈H∗
wk|β∗kh|, (2.2)
where b∗ijk is the nucleotide composition of the kth nucleotide away from the jth
nucleotide in ith gene, λ is the tuning parameter and H∗ = {C,G, T} (A was used
as baseline). The weight wk > 0 will be chosen to be proportional to a certain power
of distance between nucleotide j and the kth nucleotide in the surrounding sequence
(Zou (2006), Zhu & Liu (2009)), i.e., wk = (|k| + 1)γ. We use the LARS/Lasso
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algorithm (a.k.a. the homotopy algorithm) to find the solutions for all values of λ.
Even though the solution path for all values of λ can be effectively computed, it is
still highly desirable that one solution is given for a carefully chosen value of λ. To
choose a value of λ with a good balance of goodness-of-fit of the model and model
parsimony, we minimize the Bayesian Information Criterion (BIC).
(2.) Based on the parameters of the penalized fit in step 1, we then select the
new sequence endpoints K∗u = min{k : β∗kh 6= 0 ∀h ∈ {C,G, T}}, and K∗d = max{k :
β∗kh 6= 0 ∀h ∈ {C,G, T}}.
(3.) With the selected K∗u and K
∗
d and the dinucleotide expansion, we fit the
model (2.1) using the least squares,
G∑
i=1
Li∑
j=1
yij − α− vi −
K∗d∑
k=K∗u
∑
h∈H
βkhI(bijk = h)

2
(2.3)
where H = {CC,GG, TT,AC,CA,AG,GA,AT, TA,CG,GC,CT, TC,GT, TG}.
The model with the updated surrounding sequence and fit using the dinucleotide
expansion will then be used for estimation of gene expression levels.
2.3 Results and Discussion
2.3.1 Datasets
Our model was fitted to three genome-wide RNA-Seq datasets. These datasets will be
referred to as Wold, Burge and Grimmond as in Li et al. (2010). The Wold data, which
comes from Mortazavi et al. (2008) consists of 79, 76, and 70 million reads, which
are of length 25, generated by Illumina’s Solexa. The 79, 76, and 70 million reads
each correspond to a subdataset from brain tissue, liver tissue, and skeletal muscle
tissue, respectively. Like Li et al. (2010), when fitting the data, we will use the top
100 genes according to RPKM. So for the brain, liver and muscle Wold datasets, we
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are considering 146828, 171776 and 143570 nucleotides for each datasets’ 100 genes,
respectively. The Burge data, which comes from Wang et al. (2008) consists of three
subdatasets which will be referred to as G1, G2 and G3. G1 consists of adipose, brain
and breast tissue. G2 consists of colon, heart and liver tissue. G3 consists of lymph
node, skeletal muscle and testes tissue. Each has reads ranging from 61 to 77 million.
The datasets G1, G2, and G3 each consider 157614, 125056 and 103394 nucleotides
respectively. The Burge data was also generated from Illumina’s Solexa with reads
of length 32. Lasty, the Grimmond data, of Cloonan et al. (2008) was generated
from ABI’s SOLiD with an original read length of 35. (Some are truncated into 30
or 25 nucleotides to ensure high quality.) The data consists of two subdatasets, each
consisting of 16 million reads from each of two cell lines, which will be referred to as
EB (embryoid bodies) and ES (undifferentiated mouse embryonic stem cells). The
EB subdataset’s top 100 genes considers 51751 nucleotides and the ES subdataset
uses 64966 nucleotides. Reads were uniquely mapped using Seqmap (Jiang & Wong
(2008)) allowing for two mismatches.
We use the read counts data for the top 100 genes as prepared by Li et al. (2010).
2.3.2 Tuning the Algorithm
Our algorithm requires several tuning parameters. In this section, we present some
results of various choices we attempted for the parameters. As an assessment of
goodness-of-fit, we calculated the Bayesian Information Criterion (BIC),
BIC = −2loglike + (15K +G) log
(
G∑
i=1
Li
)
(2.4)
where the log likelihood of the fitted model is,
loglike =
G∑
i=1
Li∑
j=1
{
1
2
log
1
2piσˆ2
− (log(nij)−
̂log(nij))2
2σˆ2
}
(2.5)
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where ̂log(nij) is the fitted value of the model. σˆ2 is the estimated σ2 using the
residual sum of squares.
Determining Weights for Penalized Least Squares
In the penalized regression, γ, the power of the weights, wk = (|k| + 1)γ needs to
be determined. By fixing γ = 1, 2, . . . , 10 one-at-a-time, we calculated BIC based on
the resulting surrounding sequence, which is presented in Table 2.1. By inspecting
Table 2.1, we can find the γ which results in the best BIC. For simplicity, we opt
to use the cubic weight (γ = 3) as our final choice when determining a surrounding
sequence as it frequently preforms very well.
γ
1 2 3 4 5 6 7 8 9 10
Wold Brain 2.38 2.38 2.38 2.38 2.41 2.38 2.40 2.58 2.66 2.86
Liver 2.56 2.56 2.55 2.55 2.57 2.55 2.58 2.74 2.80 3.00
Muscle 2.75 2.74 2.74 2.74 2.76 2.74 2.75 2.87 2.93 3.09
Burge G1 2.82 2.82 2.82 2.82 2.83 2.82 2.86 2.94 2.98 3.08
G2 3.06 3.06 3.04 3.04 3.06 3.04 3.06 3.14 3.18 3.28
G3 2.96 2.95 2.94 2.94 2.96 2.93 2.97 3.06 3.12 3.22
Grimmond EB 3.51 3.51 3.51 3.51 3.56 3.51 3.54 3.59 3.64 3.76
ES 3.31 3.25 3.26 3.25 3.28 3.26 3.30 3.35 3.40 3.49
Table 2.1: Bayesian Information Criterion (BIC) for linear model with var-
ious penalty weights, γ. BICs are scaled with respect to the sample size of the
dataset.
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Determining Surrounding Sequence
In our algorithm, the distance-weighted penalized regression results in a sparse set of
parameters βkh. Since each nucleotide position has three associated βkh, we need to
translate the sparse set of parameters βkh into a sparse set of surrounding nucleotides.
In the second step of our algorithm, we select the Ku as the upmost k with all βkh 6= 0
for h ∈ {C,G, T}, and Kd as the downmost k with all βkh 6= 0 for h ∈ {C,G, T}. To
examine the effectiveness of this strategy, we compare it with an alternative strategy
which selects Ku as the upmost k with at least one of βkh 6= 0 for h ∈ {C,G, T},
and Kd as the downmost k with at least one of βkh 6= 0 for h ∈ {C,G, T}. This
alternative strategy results in a larger Ku and Kd, however after refitting with the
dinucleotide expansion, the goodness-of-fit does not improve enough to justify the
increased number of parameters. This suggests that the strategy used in step 2 is
appropriate.
Table 2.2 presents the sequence lengths determined by our algorithm.
Dataset Subdataset Upstream Downstream
Wold Brain 13 14
Liver 17 12
Muscle 13 23
Burge G1 21 20
G2 22 32
G3 25 31
Grimmond EB 24 25
ES 25 27
Table 2.2: The resulting surrounding sequence lengths upstream and down-
stream of the reads.
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This data-driven method of selecting a surrounding sequence gives different results
from that in Li et al. (2010). We find shorter surrounding sequences are needed for
the Wold datasets, but larger surrounding sequences for the Burge and Grimmond
data.
Dinucleotide composition
We also compare the linear model using neighborhood single nucleotide composition
with the linear model using our neighborhood overlapping dinucleotide compositions.
Table 2.3 presents the (negative) log likelihoods for the two models. We can see the
(negative) log likelihood of the linear model with dinucleotide composition improves
upon that with single nucleotide composition. This improvement can also be seen
through an increase in R2. For example in the Wold Brain data, R2 is increased by
25%.
Dataset Subdataset Single Nucleotide Dinucleotide
Wold Brain 1.28 1.17
Liver 1.36 1.26
Muscle 1.42 1.34
Burge G1 1.44 1.38
G2 1.54 1.48
G3 1.50 1.42
Grimmond EB 1.77 1.67
ES 1.66 1.55
Table 2.3: Negative log-likelihoods for linear models with single nucleotide
expansion and the fit with the dinucleotide expansion. Both fit with sur-
rounding sequences from Table 2.2.
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2.3.3 Comparison of Linear Models with the existing
Models
Dataset Subdataset Poisson Scaled
Poisson
Linear
Wold Brain 6.54 3.69 1.17
Liver 13.00 4.43 1.26
Muscle 17.00 4.61 1.34
Burge G1 9.32 3.97 1.38
G2 16.81 4.64 1.48
G3 15.67 4.54 1.42
Grimmond EB 89.95 6.38 1.67
ES 34.79 5.43 1.55
Table 2.4: Negative log-likelihoods for Poisson and linear models. Likelihoods
are scaled with respect to the sample size of the dataset. The Poisson models are fit
with a surrounding sequence of 40. The surrounding sequences used for the linear
model are the surrounding sequences found in Table 2.2.
We now compare our linear model with the Poisson and MART models in Li et al.
(2010). As a direct comparison of goodness-of-fit, we consider the log-likelihoods of
our linear model and the Poisson model (The MART model is an algorithmic method,
thus the log likelihood cannot be calculated). Since the read counts are clearly over-
dispersed, we also fit a scaled (over-dispersed) Poisson model as a fair comparison.
For the Poisson model, the log-likelihood is
loglike =
G∑
i=1
Li∑
j=1
{
nij
σ
log(
1
σ
nˆij
σ
)− nˆij
σ
− log nˆij!
σ
}
(2.6)
where nˆij is the fitted value of the model. For the scaled Poisson model σ is the
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dispersion parameter estimated by a quasi-likelihood method (Wedderburn (1974)).
For the unscaled Poisson model, σ is taken to be 1.
The resulting likelihood of the models for each dataset were summarized in Ta-
ble 2.4. Even after adjusting for the dispersion, we see that the linear model outper-
forms the scaled Poisson model in terms of log-likelihoods.
In addition to goodness-of-fit, the computational costs of our linear and existing
models are also compared. Table 2.5 summarize the total runtime for each method.
Dataset Subdataset Linear Poisson MART
Wold Brain 313 777 2751
Liver 394 900 3314
Muscle 220 513 1733
Burge G1 325 1478 1843
G2 344 2317 527
G3 176 648 1273
Grimmond EB 90 312 618
ES 125 594 768
Table 2.5: Runtime for the Linear, Poisson and MART Models. CPU time (in
seconds) for fitting the models obtained on a PC with an Intel Xeon E5540 processor
and 24 Gbytes of RAM running openSUSE 11.4 and R 2.12.1. When fitting the linear
model, the time used to determined the surrounding sequence is included.
When recording the runtime of the linear model, we include the time to deter-
mine the surrounding sequence and the time to refit the model with the dinucleotide
expansion. For the MART model, we use a predetermined surrounding sequence and
use the default parameters for fitting as suggested by Li et al. (2010). From Table 2.5,
we can clearly see that there is a substantial runtime difference between the Poisson
and the linear models. This observation is most notable when fitting with the dinu-
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Figure 2.3: Predicted counts for gene Tnnc2. (a) True read counts for the Tnnc2
gene of the Wold muscle data. (b) Predicted counts for the linear model for the Tnnc2
gene. (c) Predicted counts for the Poisson model for the Tnnc2 gene.
24
cleotide expansion. As an example, for the wold brain Dataset the linear model (with
sequence selection) runs roughly three times faster than the Poisson model, which
uses an iterative re-weighted least squares algorithm.
2.3.4 Estimating Gene Expression Levels
Using our linear model, we have two methods to estimate gene expression levels.
First, to estimate the gene expression for gene i, we can use αˆ+ vˆi from the estimated
model. As an alternative, we can also estimate the gene expression by bias-removed
read counts
Li∑
j=1
nij/Wi where
Wi =
Li∑
j=1
exp
(
αˆ +
K∑
k=1
∑
h∈H
βˆkhI(bijk = h)
)
(2.7)
which is the sum of the sequence bias across all the nucleotide positions of gene i.
Because there is no gold standard to validate the gene expression estimates, we
opt to correlate our estimates with the estimates using the MART model in Li et al.
(2010). We find that both methods are highly correlated with the results in Li et al.
(2010) using the non-linear MART model with the sum of sequencing preferences. Our
second method, using the sequence bias, does slightly better than the first method
based on the estimated αˆ+vˆi. Table 2.6 shows the Spearman rank correlation between
the linear model and the MART model for each dataset using the sequence bias for
gene expression estimation. Figure 2.4 compares the gene expression estimates of the
MART method and the linear model.
Our work suggests that we can use the estimates from the linear model in place
of the MART model. Since their results are very similar, the linear model may be a
better choice due to its significantly lower computation time and easily interpretable
parameters.
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Figure 2.4: Gene expression estimates of the MART and linear model. Es-
timates of the expression are plotted for the linear and MART models fit on each
subdataset of the Wold, Burge and Grimmond data. Subdatasets are differentiated
by color and point shape. Plotted on a log scale.
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Dataset Subdataset Correlation
Wold Brain 99.2
Liver 99.4
Muscle 99.3
Burge G1 96.8
G2 95.6
G3 97.2
Grimmond EB 97.4
ES 98.0
Table 2.6: Spearman rank correlations between MART and linear model
gene expression estimates.
2.4 Conclusion
We propose a linear model for the sequence bias in RNA-seq read counts data using
the neighborhood overlapping dinucleotides. We develop a penalized least squares
algorithm for model-fitting. Fitting the linear model using a penalized least squares
approach, we use weights to penalize parameters which are further away from the
read in the surrounding sequence. We then use a data-driven method to determine
an appropriate number of dinucleotides in the neighborhood sequence. Finding the
sparse set of surrounding sequence which captures as much variation of read counts as
possible results in a great savings in computational cost, especially compared with a
computationally intense method such as MART. We also find that the gene expression
estimates from our model are highly correlated with the estimates from the non-linear
model MART.
After publication of the work in this chapter, we were made aware of some addi-
tional work in correcting bias in RNA-seq. In particular, Zheng et al. (2011) directly
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corrects the gene expression estimates through nonparametric regression on all po-
tential bias factors. Zheng et al. (2011) focuses on gene level bias whereas our paper
focuses on base level (nucleotide) bias. Roberts et al. (2011b) develops a Markov
model with 744 parameters to model both gene level and base level biases. Hu et al.
(2012) develops a Poisson mixed effect model to model the base level bias one-gene-at-
a-time. The computation of the latter two methods is expensive. On the other hand,
the fragment bias considered in those papers may be integrated into our method to
further improve the accuracy of transcript quantification.
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Chapter 3
RNA-Seq Gene Expression
Quantification Using Transcript
Reads Variation
RNA-Seq, the current successor to DNA microarray technology, has become a popular
tool for transcriptome analysis (Mortazavi et al. (2008), Nagalakshmi et al. (2008),
Wilhelm et al. (2008)). By producing millions of short reads (sequences of A, C, T
and G represent nucleotides) it offers detailed insight into the transcriptome. Af-
ter mapping the reads to a reference genome or transcripts, RNA-Seq data provides
quantification information for the entire genome with nucleotide level detail. A large
amount of research has focused on transcript quantification, in particular, gene ex-
pression calculation, using these short read counts. Mortazavi et al. (2008) develop a
simple enumeration method, in which the expression level of a transcript is quantified
as reads per kilobase of the transcript per million mapped reads to the transcriptome
(RPKM). A variant, FPKM is developed in Trapnell et al. (2010) which is used for
paired-end analysis. These analysis methods assume, explicitly or implicitly, a naive
constant-rate Poisson model, Pois(λ), for short read counts and attempt to estimate
the mean, λ, using the mean read count.
Some work has shown that short-read counts have significant biases, including
sequence bias, where read counts are affected by the nucleotide composition of a sur-
rounding region, see Dohm et al. (2008), thus reducing the effectiveness of some simple
quantification methods such as RPKM. Thus, more elaborate statistical models that
can effectively remove the sequence bias of the short-read counts are highly desirable
to make transcript quantification more accurate. Li et al. (2010), Srivastava & Chen
(2010) and Bullard et al. (2010) developed Poisson regression models with variable
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rates for modeling the short-read counts. The previous chapter develops a method
using a penalized linear regression using the surround dinucleotide composition of
reads.
One issue with the Poisson models that has been observed is the presence of a
much greater variance than mean. POME, “Poisson mixed-effects model,” is another
recent model-based method developed by Hu et al. (2012) which incorporates spatial
dependence in an attempt to model this phenomena and has been shown to perform
well. Other methods include Zheng et al. (2011) which uses GC content and dinu-
cleotide composition to correct gene level bias and Roberts et al. (2011b) which uses
a complex Markov model to model both gene level and base level biases. While these
statistical models do succeed in modeling and removing some bias that exist in the
simple enumeration methods, this usually comes at the cost of significant computing
time and power.
Both the simple enumeration estimators, such as RPKM, and the statistical meth-
ods correcting for bias, use estimators based on the mean of the read counts. As an
alternative, we propose estimators based on a mixture of the mean and variance. This
is motivated by the property of the Poisson distribution that the mean and variance
are equal, which makes the read count variance a natural estimator for λ. Estimators
based on variation seem well suited as an estimator of expression levels. They place
a much higher emphasis on the few very large read counts that occur.
Similar to methods such as RPKM, these estimators based on the read variation
are simple enumeration methods which require very little computation. We demon-
strate their accuracy and speed using multiple gold standard datasets for comparison
with other methods.
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Figure 3.1: Read counts for the Fth1 gene in skeletal muscle tissue (Mor-
tazavi et al. (2008))
3.1 Methods
After reads are mapped to the genome they are summarized as read counts, meaning
at each position on the genome there will be an associated read count which quantifies
the number of reads mapped to that position. This is done in one of two ways. Read
counts can be defined as the number of reads which cover a position on the genome,
or instead we will define a read count to be the number of reads that start from a
particular position on the genome. Consider a short example gene of length ten with
sequence ACTGTGGCTA. If we have 10 ACTGT reads, 12 CTGTG reads and 8
TGTGG reads, the resulting read counts for our example gene would be 10, 12, 8 and
so on.
Let nij denote the counts of reads that are mapped to the genome starting at the
jth nucleotide of the ith gene (or transcript), where i = 1, 2, . . . , G, j = 1, . . . , Li. We
then consider a number of estimators.
First, we establish definitions of RPKM. Technically, RPKM is defined as Reads
Per Kilobase of transcript per Million mapped. Thus the RPKM of gene i is defined
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as
RPKMi =
∑Li
j=1 nij(
Li
1000
)(∑G
i=1
∑Li
j=1 nij
1000000
) (3.1)
For ease of presentation we will refer to two simplified variants of RPKM.
oRPKMi = n¯i =
∑Li
j=1 nij
Li
(3.2)
eRPKMi =
∑Li
j=1 nij∑Li
j=1 I[nij 6= 0]
(3.3)
oRPKM is simply the sample mean of the number of reads mapped to a gene
or transcript. For simplicity we do not consider the the scaling based on million
mapped reads and length of transcript. (For the comparison methods used later, the
total number of mapped reads is not relevant, however when analyzing multiple real
datasets it is important for normalization.) eRPKM is similar, however only considers
positions on the gene where reads were mapped.
We then propose a general estimator based on a mixture of the first and second
moments,
TRVi =
√√√√ 1
Li
Li∑
j=1
n2ij + (ρ
2 − 1)n¯2i (3.4)
which we call the Transcript Reads Variation, or TRV. ρ is used as a tuning
parameter which can be adjusted to place greater emphasis on the first or second
moment. With ρ = 0 this is the sample standard deviation of the reads. Likewise,
ρ = 1 gives the square root of the sample second moment. (In other words, it is
simply the the square root of the sum of the read counts divided by the length of the
transcript.) By allowing added emphasis on the squared read counts, positions with
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extremely large read counts contribute substantially more to the expression level.
We now want to provide a rationalization for the proposal of these estimates. A
common assumption is to model the read counts with a Poisson distribution. Follow-
ing this convention, we consider the true read counts to be Poisson(λi), where λi is
the population mean read counts. Similarly consider the observed read counts to be
Poisson(λOi ) and the missing read counts Poisson(λ
M
i ). These missing reads can arise
from the reads that are not mapped based on the criteria selected by the researcher or
limitations of the technology. For example, using the common mapping tool Bowtie
(Langmead et al. (2009)), a read may map with too many mismatches and is thus
discarded.
Assuming then that the true reads are the sum of the observed and the missing
reads, we wish to estimate
λi = λ
O
i + λ
M
i (3.5)
Since the Poisson distribution has the property that its mean is equal to its vari-
ance, we the use
λˆOi =
1
Li
Li∑
j=1
(nij − n¯i)2 (3.6)
to estimate λOi .
We wish to also use a variance estimator to estimate λMi . To do so we use ρ
2n¯2i ,
so
λˆMi = ρ
2n¯2i (3.7)
Then, λˆi = λˆ
O
i + λˆ
M
i becomes
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λˆi =
1
Li
Li∑
j=1
n2ij + (ρ
2 − 1)n¯2i (3.8)
which with a square root is our TRV estimator.
Through our results from real data examples, we note that ρ = 1 is a good choice
for the TRV. With ρ = 1, which is only a function of the second moment, we refer to
the estimator as TRV2, thus
TRV 2i =
√√√√ 1
Li
Li∑
j=1
n2ij (3.9)
3.2 Results
3.2.1 Datasets
Helicos Prostate Cancer Data
The first dataset contains 12 RNA samples from prostate cancer related cells which
were generated by the Chinnaiyan lab at the University of Michigan. (Sam et al.
(2011)) The data can be obtained using accession numbers SRA028835 from the
NCBI Sequence Read Archive. The samples were sequenced using the Helicos plat-
form which uses single-molecule sequencing technology, meaning reverse transcription
is avoided and the RNA is sequenced directly. By not using reverse transcription, PCR
amplification avoided, thus making it is a more direct measurement. Our method will
be applied to the reads generated from these samples using the Illumina Genome An-
alyzer and the estimates using the Helicos platform will be used as the gold standard
for comparison. The Illumina reads were aligned using Bowtie with two mismatches
allowed and the best alignment reported.
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MAQC Brain and UHR Data
The second dataset, from the MicroArray Quality Control project (MAQC Consor-
tium (2006)), contains two samples sequenced using Illumina technology. The Univer-
sal Human Reference (UHR) and Human Brain Reference (Brain) samples both have
seven lanes of sequencing available. Both can be obtained using accession numbers
SRA010153 and SRA008403 from the NCBI Sequence Read Archive. For each sample,
the MAQC project generated expression levels for over 1000 genes using quantitative
real-time reverse transcription polymerase chain reaction (qRT-PCR) using TaqMan
Gene Expression Assay. Our method will be applied to the reads generated from these
samples using the Illumina Genome Analyzer and the estimates using TaqMan Gene
Expression Assay will be used as the gold standard for comparison. Illumina reads
were aligned using Bowtie with two mismatches allowed and only unique alignments
reported.
3.2.2 Comparison to Gold Standards
We compared the various TRV estimators to both RPKM estimators as well as a
statistical method, POME, which has shown good performance. POME, or “Poisson
mixed-effects model,” is a recent model-based method developed by Hu et al., which
incorporates spatial dependence. The read counts for gene i at position j are modeled
as
nij|θi, Uij, Vij ∼ Poisson(Liθi exp[Uij + Vij])
where the fixed-effect θi is the expression level of gene i and Uij and Vij are random
effects used to account for the spatial dependence. The model is fit using Markov
chain Monte Carlo methods, which require substantial computing time.
We first compare a number of estimates to the gold standard estimates created
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Sample ρ = 0 ρ = 0.5 ρ = 1
LnCaP0 0.693 0.694 0.698
LNCaP24 0.690 0.691 0.693
LnCaP48 0.642 0.642 0.643
VCaP0 0.649 0.650 0.651
VcaP24 0.666 0.667 0.668
VcaP48 0.708 0.708 0.709
aT34 0.573 0.572 0.572
aT34N 0.511 0.511 0.511
DU145F 0.628 0.628 0.629
DU145F2 0.630 0.630 0.631
VCaP 0.527 0.526 0.525
RWPE 0.603 0.604 0.605
Table 3.1: Spearman correlation of the gold standard expressions (estimates derived
from the Helicos technology) and various estimates applied to the Illumina RNA-Seq
data for each of the twelve samples in the prostate cancer dataset. Bold correlations
indicate the highest correlation for each sample. ρ = 1 will be known as TRV2.
using the Helicos technology in the prostate cancer dataset. Table 3.1 compares the
TRV estimators with various tuning parameters to the gold standard Helicos data.
Table 3.2 shows the Spearman rank correlation of various estimates and the estimates
derived from Helicos. We see that in most samples, the TRV2 estimator achieves the
highest correlation with the gold standard.
Correlations were also calculated for some estimates and the gold standard esti-
mates in the brain and UHR MAQC datasets obtained using qRT-PCR. Table 3.3
shows the Spearman rank correlation of the various estimates compared with the
qRT-PCR estimates from the MAQC project. Also Table 3.4 shows the correlations
36
Sample eRPKM POME oRPKM TRV2
LnCaP0 0.624 0.688 0.691 0.698
LNCaP24 0.618 0.672 0.679 0.693
LnCaP48 0.600 0.640 0.619 0.643
VCaP0 0.580 0.604 0.650 0.651
VcaP24 0.598 0.623 0.666 0.668
VcaP48 0.622 0.656 0.697 0.709
aT34 0.578 0.595 0.527 0.572
aT34N 0.428 0.394 0.497 0.511
DU145F 0.594 0.635 0.584 0.629
DU145F2 0.593 0.626 0.587 0.631
VCaP 0.520 0.517 0.497 0.525
RWPE 0.560 0.601 0.597 0.605
Table 3.2: Spearman correlation of the gold standard expressions (estimates derived
from the Helicos technology) and TRV estimators with various tuning parameters
applied to the Illumina RNA-Seq data for each of the twelve samples in the prostate
cancer dataset. Bold correlations indicate the highest correlation for each sample.
TRV2 is TRV with ρ = 1.
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Figure 3.2: Gold standard expressions (estimates derived from the Helicos technology)
plotted against TRV2 on a square root scale for the LnCap0 and VCaP0 samples.
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Lane Genes eRPKM oRPKM TRV2
1 749 0.760 0.772 0.778
2 756 0.757 0.783 0.790
3 750 0.753 0.775 0.783
4 761 0.752 0.782 0.788
5 763 0.769 0.784 0.791
6 752 0.749 0.785 0.791
7 757 0.747 0.783 0.789
Table 3.3: Spearman correlation of the gold standard expressions (estimates derived
from the qRT-PCR MAQC data) and TRV2 applied to the Illumina RNA-Seq data
for each of the eight replicates from the MAQC brain dataset. Bold correlations
indicate the highest correlation for each replicate.
for the UHR dataset.
In both datasets, the TRV2 achieves the highest Spearman correlation most often.
Figure 3.3 also shows that these results holds for smaller datasets using the most
highly expressed genes. This is especially important as highly expressed genes are
frequently of greater interest.
3.2.3 Computation
In addition to the improvements in estimation, the proposed estimator is computa-
tionally very simple. For example, running on a desktop PC (Intel i5-2500K processor
running Ubuntu 10.04), the POME method needed 50 minutes to model a single gene
from one of the samples in the prostate cancer data. The TRV2 estimator, run on
the entire sample from the prostate cancer data (nearly 5000 genes) requires only
a few seconds. While statistical modeling may provide some additional insight, the
additional computation time is a large burden, especially for experiments considering
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Figure 3.3: Spearman correlation of the gold standard expressions (estimates derived
from the Helicos technology) and various estimates applied to the Illumina RNA-
Seq data for a various number of genes within single samples of the prostate cancer
dataset. The genes are sorted by Helicos expression and the subdatasets are created
based on the highest expressed genes for datasets of each specified size.
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Lane Genes eRPKM oRPKM TRV2
1 744 0.770 0.810 0.815
2 773 0.821 0.826 0.833
3 775 0.815 0.823 0.830
4 776 0.815 0.821 0.828
5 778 0.824 0.826 0.834
6 763 0.810 0.822 0.829
7 768 0.808 0.820 0.825
Table 3.4: Spearman correlation of the gold standard expressions (estimates derived
from the qRT-PCR MAQC data) and TRV2 applied to the Illumina RNA-Seq data
for each of the eight replicates from the MAQC UHR dataset. Bold correlations
indicate the highest correlation for each replicate.
multiple replicates from multiple conditions.
3.3 Conclusion
We propose estimates of gene expression quantification based on the variation of
RNA-Seq short read counts. While most methods are based on first order moments,
mainly the mean, our novel method using second order moments, selected from a
mixture of first and second moments, shows improvement over these methods. By
using an enumeration method, our approach is very computationally simple as well
as extremely fast compared to statistical methods which require large amounts of
computation time for modeling. In addition to the ease and speed of computation,
the method proposed sees improvements in comparison to gold standards over other
much more complicated methods.
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Chapter 4
Identification Of Regulatory
Elements Using Next-Generation
Sequencing Data
As outlined in the central dogma of molecular biology, genetic information is passed
from DNA to mRNA through gene transcription. This gene transcription is regu-
lated through transcription factors, a regulatory protein, which binds to sequences
of nucleotides in gene promoter regions. Identifying the transcription factors for a
given biological process is of great importance for the understanding of gene tran-
scription. RNA-Seq is a high-throughput sequencing technology which sequences the
entire genome, providing measurement of gene expression levels, the number of copies
of the mRNA of each gene. Using the RNA expression levels from RNA-Seq experi-
ments, coupled with DNA sequencing data we develop a method to identify regulatory
elements. The proposed algorithm relies on a semi-parametric model with multiple
responses considered simultaneously. The method does not require a specific linear
model assumption which is an advantage over many existing methods. The excellent
performance of the method is demonstrated through simulation study and a real data
example using samples from Drosophila melanogaster.
4.1 Introduction
While gene expression is ultimately the result of the coding sequences of DNA which
are considered genes, non-coding DNA is known to play an important role in this
process. While the function of all non-coding DNA is currently unknown, the role of
certain regions is understood. One such region, a sequence of roughly 100 to 1000
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base pairs upstream the DNA of a gene is called the promoter region. This region can
play an important role in the transcription of the corresponding gene. Proteins called
transcription factors are known to bind to certain sequences in promoter regions, thus
regulating the transcription of the gene. Common patterns of nucleotides present
in a promoter’s DNA which are recognized by the transcription factors are called
transcription factor binding motifs. (TFBM) Identification of these binding sites are
important in the understanding of gene regulatory circuitry. Fundamentally it is
assumed that a greater presence of a particular TFBM in a promoter region makes
for easier detection for transcription factors and thus allows for a greater effect on
the regulation of the resulting transcription. We develop a method which attempts
to identify those TFBM which are most important to the regulation of transcription.
4.2 Method
Given a sample of n random variables, (X1, Y1), . . . (Xn, Yn), with X ∈ Rp and Y ∈ Rq
we wish to find a subset of variables XA which best predict the multivariate response
variables Y. The method proposed in this chapter will be used in order to identify
the regulatory elements of a transcriptome using gene expression levels from RNA-
Seq experiments. We consider a dimension reduction model framework. With βi =
(β1i, β2i, . . . , βpi) the model assumes Y and X are mutually independent conditional
on β′1X, β
′
2X, . . . , β
′
KX, i.e.
Y ⊥ X|B′X
where B = (β′1, β
′
2, . . . , β
′
K).
We will adapt a method for a single variate Y , correlation pursuit (COP), (Zhong
et al. (2012)) which is a stepwise variable selection procedure that relies on Sliced
Inverse Regression (SIR). (Li (1991)) COP provides the ability to perform variable
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selection when p > n, a condition which may frequently arise when using genomic
data. Consider the squared profile correlation between Y and β′X given by
ρ2(β) = max(corr2(T (Y ), β′X))
which defines the largest possible correlation between the transformed response
T (Y ) and the projection β′X. Then βi is the ith eigenvector and ρ2(βi) = λi, which
can be estimated by λˆi for i = 1, 2, . . . , K.
With an initial index of selected variables, A, COP performs both an addition and
deletion step. For the addition step, SIR is performed on XA to obtain the estimated
squared profile correlations λˆA1 , λˆ
A
2 , . . . , λˆ
A
K . Then consider the COP statistic
COPA+ti =
n(λˆA+ti − λˆAi )
1− λˆA+ti
which measures the contribution of adding Xt to the ith profile correlation. Then
define
COP
A
1:K = maxt∈Ac
(
K∑
i=1
COPA+ti
)
.
The COP procedure can then be described as:
• Step 1: Set number of principal directions K and thresholds αin and αout.
• Step 2: Randomly select K + 1 variables for an initial set A.
• Step 3: Iterate through the addition and deletion steps until neither can be
performed.
• Addition: Among unselected variables, find the variable t that achieves COPA1:K ,
thus has the most contribution to the squared profile correlation. If COP
A
1:K >
αin, add Xt to the set of selected variables XA.
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• Deletion: Among selected variables, find the variable t that achieves COPA1:K ,
thus contributes the least to the squared profile correlation. If COPA1:K < αout,
remove Xt from the set of selected variables XA.
• Step 4: Output A, the selected subset of variables.
4.2.1 Multivariate Extension
We now develop a new method which uses the correlation pursuit methods defined
above to consider multiple responses simultaneously. We use canonical correlation
analysis to find linear combinations of Y with the maximum correlation to the X
matrix. Let a1, a2, . . . , aq define these linear transformations of Y . Then for each
aT1 Y, a
T
2 Y, . . . , a
T
q Y we perform the COP analysis to find the significant X variables
for each transformed Y variable. Call these selected variables XA1 , XA2 , . . . , XAq . By
combining these, we have the subset of selected variables, XA = (XA1 , XA2 , . . . , XAq).
Thus the total procedure is as follows:
• Step 1: Obtain aT1 Y, aT2 Y, . . . , aTq Y using canonical correlation analysis.
• Step 2: For each aT1 Y, aT2 Y, . . . , aTq Y , perform COP analysis to obtain
XA1 , XA2 , . . . , XAq .
• Step 3: Output XA = (XA1 , XA2 , . . . , XAq).
4.3 Simulation Results
In order to establish the effectiveness of the proposed methods, a number of simulation
studies were preformed. We have applied our method to both linear and nonlinear
models to demonstrate its effectiveness in variable selection.
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4.3.1 Linear Model
We first fit a linear model with uncorrelated xi’s. Let Y be n x q and let X ∼ N(0, Ip)
be n x p, then the model takes the form
Y = Xβ + 
where  ∼ N(0, Iq). With n = 200, q = 5 and various values of p, each column of
β is generated using p Bernoulli trials. Table 4.1 summarizes the results. Note that
p∗ denotes the average number of true variables from the simulated Bernoulli trials.
A low number of false positives is seen throughout while maintaining infrequent false
negatives. Table 4.2 displays the results for case with p > n.
p 10 20 30 40 50 60 70 80 90 100
Ave. FP 1.85 0.97 0.54 0.45 0.5 0.54 0.78 0.94 1.1 1.38
Ave. FN 0 0 0 0 0 0 0 0.1 0.21 0.24
Ave. p∗ 3.04 6.54 9.49 13.37 16.42 19.88 22.79 25.95 29.45 32.7
Table 4.1: Accuracy of variable selection for the uncorrelated linear model.
For each value of p, the data are generated 100 times, and the model selects significant
variables. The table shows the average false positives (FP), false negatives (FN)
and the average number of true variables, p∗. The model is fit using αin = 0.999,
αout = 0.9, H = 10 slices, and K = 1 direction.
We also fit a linear model with correlated xi’s, namely  ∼ N(0, Iq + 0.5 ∗∆) and
∆ is a matrix of 1’s. Table 4.3 summarizes the results. Again, note that p∗ denotes
the average number of true variables from the simulated Bernoulli trials. A similarly
low number of false positives is seen throughout while again maintaining infrequent
false negatives. Table 4.4 displays the results for case with p > n.
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p 250 500
Average FP 2.5 7.2
Average FN 0 0.35
Ave. p∗ 12.85 23.75
Table 4.2: Accuracy of variable selection for the uncorrelated linear model
for large values of p. For each value of p, the data are generated 20 times, and the
model selects significant variables. The table shows the average false positives (FP),
false negatives (FN) and the average number of true variables, p∗. The model is fit
using αin = 0.999, αout = 0.99, H = 10 slices, and K = 1 direction.
p 10 20 30 40 50 60 70 80 90 100
Ave. FP 1.77 0.98 0.54 0.51 0.58 0.79 0.83 0.91 0.99 1.11
Ave. FN 0 0 0 0 0 0 0.04 0.07 0.4 0.42
Ave. p∗ 3.37 6.55 9.79 12.47 16.52 19.85 22.34 25.63 29.57 32.71
Table 4.3: Accuracy of variable selection for the correlated linear model. For
each value of p, the data are generated 100 times, and the model selects significant
variables. The table shows the average false positives (FP), false negatives (FN)
and the average number of true variables, p∗. The model is fit using αin = 0.999,
αout = 0.99, H = 10 slices, and K = 1 direction.
4.3.2 Nonlinear Model
We also considered a nonlinear model. Let Y be n x q and let X ∼ N(0, Ip) be n x
p, then the model takes the form
Y1 = sign(x1 + x2) + 0.2
Y2 = 2(x3 + x4) + exp(x5 + x6) + 0.2
Y3 = Y1 ∗ Y2 + 0.5
where  ∼ N(0, 1). With fixed true variables, x1, x2, . . . , x5 we repeat the simula-
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p 250 500
Average FP 3.50 6.25
Average FN 0 0.9
Ave. p∗ 11.10 23.25
Table 4.4: Accuracy of variable selection for the correlated linear model for
large values of p. For each value of p, the data are generated 20 times, and the
model selects significant variables. The table shows the average false positives (FP),
false negatives (FN) and the average number of true variables, p∗. The model is fit
using αin = 0.9999, αout = 0.9, H = 10 slices, and K = 1 direction.
tion procedure from above with n = 200, q = 3, and various values of p. For each value
of p the number of true variables is held constant at 5. The results are summarized
in Table 4.5. Table 4.6 displays the results for case with p > n.
p 10 20 30 40 50 60 70 80 90 100
Average FP 1.19 1.59 1.77 2.06 2.20 2.37 2.45 2.79 3.05 3.11
Average FN 0 0 0 0 0 0 0 0 0 0
Table 4.5: Accuracy of variable selection for the nonlinear model. For each
value of p, the data are generated 100 times, and the model selects significant vari-
ables. The table shows the average false positives (FP) and false negatives. (FN) For
each value of p the number of true variables is 5. The model is fit using αin = 0.999,
αout = 0.9, H = 10 slices, and K = 2 directions.
4.4 Data
The dataset used in this analysis consists of 9398 Drosophila Melanogaster (fruit fly)
genes using data from the modENCODE project described in Celniker et al. (2009).
RNA isolation and library preparation were performed by the Peter Cherbas group
and the Brenton Graveley lab. Sequencing was performed using the Illumina Genome
Analyzer II platform by the Susan Celniker lab, the Brenton Graveley lab, the Tom
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p 250 500
Average FP 2.15 1.85
Average FN 0 0.05
Table 4.6: Accuracy of variable selection for the nonlinear model for large
values of p. For each value of p, the data are generated 20 times, and the model
selects significant variables. The table shows the average false positives (FP) and false
negatives. (FN) For each value of p the number of true variables is 5. The model is
fit using αin = 0.9999, αout = 0.99, H = 10 slices, and K = 2 directions.
Gingeras lab, and the Michael Brent lab. Reads of length 76 were uniquely aligned
to the Drosophila melanogaster r5 genome using Bowtie.
We use six samples from Drosophila melanogaster (fruit fly) data taken during
the early embryonic stage. For each sample, mRNA expression levels were calculated
using the short-reads from the RNA-Seq experiments. Specifically, gene expression
was quantified using RPKM values from Cuﬄinks software. (Roberts et al. (2011a))
Again, RPKM is calculated for each gene as
RPKM =
∑Li
j=1 nij(
Li
1000
)(∑G
i=1
∑Li
j=1 nij
1000000
) (4.1)
which normalizes for both total number of reads per sample as well as length of
gene. Let yiq = the RPKM of gene i from sample q.
Candidate regulatory motifs were found using MDscan which searches for DNA
sequence motifs representing the protein-DNA binding sites. (Liu et al. (2002)) Motif
scores are based on the abundance and intensity of motif k in the promoter region
upstream of gene i. A higher abundance of a motif makes it easier for the transcription
factor to find the motif. Higher abundance of a motif should then lead to higher levels
of expression for genes which it regulates. Let xij = motif score of motif j for gene
i. Specifically, using MDscan, first denote each TFBM candidates by m1,m2, . . . ,mp
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and their consensus matrices by θ1, θ2, . . . , θp then the motif score is
xij = log2
ni−wj∑
k=1
P (si,k|θj)
P (si,k|θ0) (4.2)
where ni is the length of the promoter region for gene i, wj is the width of the
candidate motif mj, θ0 is the third-order Markov model parameter estimated from
intergenic sequences and si,k is the sequence segment of width wj starting at the k-
th position in the promoter region of gene i. The consensus matrices are otherwise
known as the position-specific weight matrices (PSWM) which are a representation
of motifs in biological sequences. For DNA, a PSWM contains four columns, one for
each possible nucleotide and in this case wj rows for each possible position. A specific
cell of the matrix represents, say the cell for the nucleotide G at position 5, gives the
proportion of times the G nucleotide appears at position 7 among all sequences of
the correct width in the promoter region which are similar to the candidate motif.
(MDscan calculates the number of bases which must match for a sequence to be called
similar based on the width of the candidate motif.) An example PSWM is shown in
Table 4.7.
The resulting dataset uses 9398 genes to select from 2391 candidate motifs.
4.5 Results
From 2391 candidate motifs, 62 motifs are chosen by the proposed method. Using
only the chosen motifs from each transformed Y variable to refit the model using
Sliced Inverse Regression, the eigenvectors suggest a possible groupings of the motifs.
From the first transformed variable, two groups in particular stand out and their
motifs are listed in Table 4.8.
Both groups appear to be involved in the regulation of morphogenesis. Specifically
the first group is involved in development of the eye, central nervous system and
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Position A C G T Con
1 1.08 13.92 7.25 77.75 T
2 1.08 0.58 97.25 1.08 G
3 6.64 0.58 0.58 92.19 T
4 1.08 0.58 0.58 97.75 T
5 8.86 3.92 7.25 79.97 T
6 1.08 77.25 6.14 15.53 C
7 85.53 0.58 0.58 13.31 A
Table 4.7: Position-specific weight matrix. Example MDscan output of a PSWM
for a motif with consensus sequence TGTTTCA.
Motifs
Group 1
byn,Kr,Mad,sna,Eip74EF,Aef1,HLHm5,Adf1,
BEAF-32B,Top2,bab1,gsb-n
Group 2
cad,bin,Med,Hr46,p120,br-Z4,srp,exd,
BEAF-32,Cf2-II,ey,hkb
Table 4.8: Selected motifs for the Drosophila Melanogaster dataset.
sensory organs. The second group contains transcription factor binding motifs for
development of the digestive system and musculature. The motif logos, a graphical
representation of the position weight matrix, for the first group are displayed in
Figure 4.1.
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Figure 4.1: Motif logos for 12 of thee selected motifs, which correspond to Group 1
above.
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Chapter 5
Identifying Differentially Expressed
Genes Using Timecourse RNA-Seq
Short-Read Count Data
A frequent problem in bioinformatics is discovering differentially expressed genes
across varying conditions. Until recently, DNA microarrays were the technology of
choice for this task, however recently RNA-Seq has emerged as the preferred tech-
nology. RNA-Seq provides a deeper picture of RNA expression levels, specifically
nucleotide level resolution, which we will leverage in a method for identifying dif-
ferentially expressed genes in time course experiments. In other words, RNA-Seq
technology gives an expression level for each nucleotide position. Thus the proposed
method could fit curves for the time varying expression at each nucleotide of a par-
ticular gene. For computational performance reasons, we will compromise between
gene level and nucleotide level resolution and use expression at the exon level when
fitting our proposed model.
A large and growing number of works have focused on identifying differentially
expressed genes using next-generation RNA-Seq technology, however they are largely
interested in experiments without time-condition interactions. (Trapnell et al. (2012),
Wang et al. (2010), Robinson et al. (2010).) We will call these differentially expressed
genes which lack a time-condition interaction parallel differentially expressed genes.
(PDE genes.) The genes which we hope to identify as having a significant time-
condition interaction will be referred to as non-parallel differentially expressed genes.
(NPDE genes.) A recent work Oh et al. (2013) models this time dependence us-
ing various methods including an autoregressive time-lagged regression and a hidden
Markov model. Unfortunately, such models require the Markov property, which is
53
unlikely to hold for most time course RNA-seq data.
The method proposed here will use the functional ANOVA mixed-effect model
proposed in Ma et al. (2009) for modeling time course exon-level expression data.
These functional ANOVA models, as seen in Wahba (1990) and Gu (2013), contain
the useful property that it can be easily decomposed into bivariate functions of time
and treatments, much like classical ANOVA and the corresponding notions of main
effects and interactions. The random effects model the time-dependent correlation
structure, while the fixed effect reflect the main effects and interactions.
To determine differential expression, we develop an index based on the Kullback-
Leibler distance which will simultaneously identify both NPDE and PDE genes. Un-
der the proposed functional ANOVA model, a significant interaction term will coincide
with a NPDE gene.
The method will be tested on datasets created from Drosophila melanogaster.
5.1 Negative Binomial Mixed-effect Model
In this section and hereafter we develop a negative binomial mixed-effect model for
modeling time course exon-level expression RNA-seq read counts.
5.1.1 The Model Specification
The mapped read counts of a gene at time ti of exon k in condition (treatment group)
g, denoted by Yigk, is assumed to have negative binomial distribution,
Yigk ∼ NegBin(ν, p(ti, g, k)) (5.1)
where the negative binomial distribution has a density
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P (Yigk = y) =
Γ(ν + y)
y!Γ(ν)
p(ti, g, k)
ν(1− p(ti, g, k))y (5.2)
where i = 1, · · · , n, k = 1, · · · , K, g = 1, · · · , G, and n is the number of time
points, K is the number of exons, and G is the number of groups. To characterize the
time course correlation, we model the read counts using a nonparametric mixed-effect
model
log{p(ti, g, k)/(1− p(ti, g, k))} = η(ti, g) + zTkbk, (5.3)
where the population mean time course profile is described by the bivariate func-
tion η which is assumed to be a smooth function of time t for each group g, bk are the
exon specific random intercepts to model intra-exon variation with bk ∼ N(0, B), and
zk are the corresponding design vector for random effect; see, e.g., Gu & Ma (2005b).
The random effect covariance matrix B is to be estimated from the data. By using
different specifications of b and associated design vector z, model (5.3) can accommo-
date various correlation structures. A simple example is to set bk = bk and z
T
kbk = bk,
we have B = σ2b and the same correlation across time.
In the model (5.3), the bivariate function η may be further decomposed as
η(t, g) = η∅ + η1(t) + η2(g) + η1,2(t, g), (5.4)
where η∅ is the overall mean, η1(t) is the time effect at time t, η2(g) is the treatment
effect of the gth group, η1,2(t, g) is the effect of the interaction between time and
treatment. Both time effect and treatment effect are defined as deviation from the
overall mean, so
∫ T
0
η1(t)dt = 0 and
∑G
g=1 η2(g) = 0. Similarly, the time-treatment
interaction are defined as
∫ T
0
η1,2(t, g)dt = 0 for all g, and
∑G
g=1 η1,2(t, g) = 0 for all t.
Such decomposition extends the classical ANOVA decomposition on discrete do-
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mains to generic domains, and is referred to as functional ANOVA decomposition
(Wahba (1990), Gu (2013)). When the time-treatment interaction term η1,2(t, g) is
significant, we have different trajectories for population mean time course profiles in
different treatment groups , i.e., η(t, g1) − η(t, g2) = η2(g1) − η2(g2) + η1,2(t, g1) −
η1,2(t, g2) for every t, where the first two terms in the right hand side of the equation
are constant, and the second two terms in the right hand side of the equation vary
with t.
If the time-treatment interaction η1,2(t, g) is not significant in the functional
ANOVA model (5.4), one may adequately fit an additive model
η(t, g) = η∅ + η1(t) + η2(g), (5.5)
which yields parallel population mean time course profiles in different treatment
groups, i.e., η(t, g1)− η(t, g2) = η2(g1)− η2(g2) for every t, where the right hand side
of the equation is a constant.
To compare the expression profiles, we refer to the genes with significant time-
treatment interaction term in (5.4), i.e., η1,2(t, g) 6= 0, as non-parallel differentially
expressed genes; the genes with significant main effect in treatment g but no time-
treatment interaction in (5.5), i.e., η2(g) 6= 0 and η1,2(t, g) = 0, are referred to as
parallel differentially expressed (PDE) genes. The methods to distinguish non-parallel
differentially expressed genes from parallel differentially expressed genes are currently
still lacking.
5.1.2 Estimation
The model (5.3) is estimated using the penalized Henderson’s likelihood (Gu & Ma
(2005a)) through minimizing
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n∑
i=1
G∑
g=1
K∑
k=1
{
(ν + Yigk) log(1 + exp{η(ti, g) + zTkb})− ν[η(ti, g) + zTkb]
}
+
K∑
k=1
σ2bTkB
−1bk +NλJ(η), (5.6)
where N =
∑G
g=1
∑K
k=1 n = nGK, the quadratic functional J(η) quantifies the
roughness of η and the smoothing parameter λ controls the trade-off between the
goodness-of-fit and the smoothness of η.
5.2 Individual Gene Significance Testing
To identify non-parallel differentially expressed genes, we are interested in testing for
a significant time-treatment interaction,
H0 : η1,2(t, g) = 0; H1 : η1,2(t, g) 6= 0 (5.7)
in the nonparametric model (5.3) with functional ANOVA (5.4).
Due to a lack of an easily computed sampling distribution which would allow for a
derivation of the usual F statistic, we shall now derive an index based on the Kullback-
Leibler ratio. The Kullback-Leibler distance for the specified negative binomial model
is given by
KL(η˜, η) =
1
N
n∑
i=1
G∑
g=1
K∑
k=1
{
ν
p(ti, g, k))
log
1− p(ti, g, k)
1− p˜(ti, g) + ν(η(ti, g)− η˜(ti, g))
}
.
(5.8)
We then note that, for two models, ηˆF (a full model given in H1) and ηˆR (a reduced
model specified in H0), as well as ηC , a constant regression function, we have
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KL(ηˆF , ηC) = KL(ηˆF , ηˆR) +KL(ηˆR, ηC). (5.9)
We will then use the following Kullback-Leibler distance ratio as our index
KLR =
KL(ηˆF , ηˆR)
KL(ηˆF , ηC)
(5.10)
which, when small, indicates that little is lost by omitting the additional terms
from H1. While not a test statistic, we will still refer to H0, H1 and testing for ease
of explanation.
Given genes that are not significant non-parallel differentially expressed, we may
further investigate whether they are significant parallel differentially expressed genes.
That is in model (5.3) with functional ANOVA (5.5), we are interested in testing
H0 : η2(g) = 0; H1 : η2(g) 6= 0 (5.11)
which can be carried out in the same manner as the test for time-treatment inter-
action.
5.3 Results
5.3.1 Drosophila Melanogaster RNA-Seq Data
The dataset used in the analysis consists of 1094 Drosophila Melanogaster (fruit fly)
genes using data from the modENCODE project described in Celniker et al. (2009).
RNA isolation and library preparation were performed by the Peter Cherbas group
and the Brenton Graveley lab. Sequencing was performed using the Illumina Genome
Analyzer II platform by the Susan Celniker lab, the Brenton Graveley lab, the Tom
Gingeras lab, and the Michael Brent lab. Reads of length 76 were uniquely aligned
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Figure 5.1: Simplied structure of a gene. Shows the progression from a DNA
gene containing both introns and exons to an RNA transcript containing only exons.
For simplicity both transcripts and genes are referred to as genes.
to the Drosophila melanogaster r5 genome using Bowtie.
The data as prepared for this work consists of two groups of five timepoints. The
first groups contains five timepoints each spaced two hours apart early in the embroyic
stage. The second group again consists of give timepoints each spaced two hours apart
in the late embroyic stage.
For computational efficiency, instead of considering each nucleotide of each gene
individually, the exons of each gene are considered. Figure 5.1 shows a simplified
structure of a gene which shows how an mRNA transcript (“gene”) is made up of
exons. So, Yigk denotes with number of reads mapping to the kth exon of the gth
group for the ith timepoint.
Currently naive normalization is performed by first determining the number of
million reads mapped to each timepoint then scaling each timepoint to match the
timepoint with the lowest number of reads. Some rounding is necessary to maintain
count data which at most adds or removes one additional read to an exon.
5.3.2 Selected Genes
The negative binomial mixed-effect model was used to identify non-parallel differen-
tially expressed genes among the 1094 genes in the Drosophila Melanogaster. The
model is fit gene-by-gene and the relevant Kullback-Leibler ratios, from 5.10, are
stored for each gene.
59
llllllllll
lllllllllllll
llllllllllll
llllllllll
llllllll
llllllll
lllllll
llllll
llllll
lllll
lllll
lllll
llll
llll
llll
llll
llll
llll
llll
llll
lll
lll
lll
llll
llll
llll
lll
lll
lll
lll
lll
lll
l
ll
lll
lll
lll
ll
lll
ll
ll
ll
lll
ll
ll
ll
ll
ll
ll
l
ll
ll
ll
ll
0 200 400 600 800 1000
0.
0
0.
2
0.
4
0.
6
0.
8
Genes
Ku
llb
ac
k−
Le
ib
le
r R
at
io
Figure 5.2: Kullback-Leibler Ratio for tesing η1,2(t, g) = 0. Sorted values of
the Kullback-Leibler ratio for testing η1,2(t, g) = 0 for each gene in the Drosophila
melanogaster dataset which was considered.
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Figure 5.3: Kullback-Leibler Ratio for tesing η2(g) = 0. Sorted values of
the Kullback-Leibler ratio for testing η2(g) = 0 for each gene in the Drosophila
melanogaster dataset which was considered.
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Figure 5.2 shows the sorted Kullback-Leibler ratios, with ηF = η∅+η1(t)+η2(g)+
η1,2(t, g) and ηR = η∅ + η1(t) + η2(g), for each gene used in the analysis. From
Figure 5.2 we use KLR = 0.65 as a cutoff for labeling a gene NPDE. With this
cutoff, 86 of the 1094 genes are labeled as NPDE. Figure 5.4 and Figure 5.5 show
a selected NDPE gene, “mid.” This gene has KLR = 0.83 for testing η1,2(t, g) = 0
and KLR = 0.98 for testing η2(g) = 0. So while the usual methods for determining
differential expression would likely identify this gene, they would not have evidence
to support the existence of a time-treatment interaction. Similarly, Figure 5.6 and
Figure 5.7 show a selected NDPE gene, “RpL37A.” This gene has KLR = 0.93 for
testing η1,2(t, g) = 0 and KLR = 0.25 for testing η2(g) = 0. Unlike the “mid” gene,
this gene would likely not be identified as differentially expressed using methods that
do not test for a time-treatment interaction.
Figure 5.3 shows the sorted Kullback-Leibler ratios, with ηF = η∅ + η1(t) + η2(g)
and ηR = η∅ + η1(t), for each gene used in the analysis. From Figure 5.3 we suggest
KLR = 0.8 as a cutoff for labeling a gene PDE which was not selected as NPDE.
This is a somewhat subjective cutoff and should ultimately be determined by the
experimenter. Also, existing methods could be used to determine genes that are
differentially expressed once NPDE genes have already been determined. Figure 5.8
and Figure 5.9 show a selected PDE gene, “wupA” which has KLR = 0.05 for testing
η1,2(t, g) = 0 and KLR = 0.894 for testing η2(g) = 0.
5.4 Discussion
In this chapter, we propose a statistical method for identifying non-parallel differen-
tially expressed genes arising from timecourse RNA-Seq experiments. A functional
ANOVA mixed-effect model is employed to model the timecourse gene expression
using exon level read counts. We develop an index using the Kullback-Leibler ratio
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Figure 5.4: Drosophila Melanogaster Gene “mid”. Gene “mid” from the
Drosophila melanogaster dataset which was identified as non-parallel differentially
expressed with a KLR of 0.83 for testing η1,2(t, g) = 0. The first panel shows the
early group while the second panel show the late group. The lines shows the change
in read counts of a specific exon over time.
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Figure 5.5: Drosophila Melanogaster Gene “mid”. Gene “mid” from the
Drosophila melanogaster dataset which was identified as non-parallel differentially
expressed with a KLR of 0.83 for testing η1,2(t, g) = 0. Blue dots represent the early
group while orange dots represent the late group. Blue lines correspond to the fitted
model for the early group, with the orange used again for the late group. The thick
lines are used to plot η(t, g).
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Figure 5.6: Drosophila Melanogaster Gene “RpL37A”. Gene “RpL37A” from
the Drosophila melanogaster dataset which was identified as non-parallel differentially
expressed with a KLR of 0.93 for testing η1,2(t, g) = 0. The first panel shows the early
group while the second panel show the late group. The lines shows the change in read
counts of a specific exon over time.
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Figure 5.7: Drosophila Melanogaster Gene “RpL37A”. Gene “RpL37A” from
the Drosophila melanogaster dataset which was identified as non-parallel differentially
expressed with a KLR of 0.93 for testing η1,2(t, g) = 0. Blue dots represent the early
group while orange dots represent the late group. Blue lines correspond to the fitted
model for the early group, with the orange used again for the late group. The thick
lines are used to plot η(t, g).
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Figure 5.8: Drosophila Melanogaster Gene “wupA”. Gene “wupA” from the
Drosophila melanogaster dataset which was identified as parallel differentially ex-
pressed with a KLR of 0.89 for testing η2(g) = 0. The first panel shows the early
group while the second panel show the late group. The lines shows the change in read
counts of a specific exon over time.
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Figure 5.9: Drosophila Melanogaster Gene “wupA”. Gene “wupA” from the
Drosophila melanogaster dataset which was identified as parallel differentially ex-
pressed with a KLR of 0.89 for testing η2(g) = 0. Blue dots represent the early group
while orange dots represent the late group. Blue lines correspond to the fitted model
for the early group, with the orange used again for the late group. The thick lines
are used to plot η(t, g).
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in order to detect both non-parallel differentially expressed genes as well as parallel
differentially expressed genes which lack a time-treatment interaction.
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Appendix
Package ‘lmbc’
June 27, 2014
Type Package
Title Linear Model Bias Correction for RNA-Seq Data
Version 0.9.1
Date 2011-2-2
Author David Dalpiaz
Maintainer David Dalpiaz dalpiaz2@illinois.edu
Depends mseq, lars
Description This is the package for implementing the method in “Bias Correction
in RNA-Seq Short-read Counts using Penalized Regression.” It first uses a
penalized regression to determine an appropriate surrounding sequence, then
refits the model using the dinucleotide expansion.
License GPL (≥ 2)
URL http://www.r-project.org
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Function: lmbc
Description
This function implements the method in ”Bias Correction in RNA-Seq Short-read
Counts using Penalized Regression.” It first using a penalized regression to determine
an appropriate surrounding sequence, then refits the model using the dinucleotide
expansion.
Usage
lmbc(data, up, down, power)
Arguments
data Data in the format accepted by the mseq package, for use with its expan-
sion function.
up Length of the initial upstream sequence.
down Length of the initial downstream sequence.
power Additional parameter for weighted fit penalty. Default and recommended
is 3.
Values
seqLen Length of resulting sequence.
lasL Length of resulting upstream sequence.
lasR Length of resulting downstream sequence.
r2 Coefficient of determination for the model.
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logLik Log-likelihood of the model.
References
Dalpiaz, D., He, X., and Ma, P. (2012) Bias correction in RNA-Seq short-read counts
using penalized regression , Statistics in Biosciences , DOI: 10.1007/s12561-012-9057-
6.
Examples
data(g1_part)
lmbc.ex <- lmbc(g1_part,40,41,3)
Source
lmbc <- function(data,up,down,power)
{
data <- expData2nt(g1_part, up, down)
numGenes <- length(unique(data$index)) # number of genes in dataset
createPosition <- function(numGenes,up,down){
position = numeric(0)
for(i in up:1)
{
position = append(position,rep(i,3))
}
position = append(position,rep(0,3))
for(i in 1:(down-1))
{
position = append(position,rep(i,3))
}
position + 1
}
lasso.adapt.bic2 <- function(x,y,z,position){
# adaptive lasso from lars with BIC stopping rule
# this one uses the "known variance" version of BIC with RSS/(full model mse)
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# must use a recent version of R so that normalize=FALSE can be used in lars
require(lars)
ok<-complete.cases(x,y)
x<-x[ok,] # get rid of na’s
y<-y[ok] # since regsubsets can’t handle na’s
m<-ncol(x)
n<-nrow(x)
x<-as.matrix(x) # in case x is not a matrix
# standardize variables like lars does
one <- rep(1, n)
meanx <- drop(one %*% x)/n
xc <- scale(x, meanx, FALSE) # first subtracts mean
normx <- sqrt(drop(one %*% (xc^2)))
names(normx) <- NULL
xs <- scale(xc, FALSE, normx) # now rescales with norm (not sd)
out.ls=lm(y~xs) # ols fit on standardized
beta.ols=out.ls$coeff[2:(m+1)] # ols except for intercept
w=(position)^z
xs=scale(xs,center=FALSE,scale=w) # xs times the weights
object=lars(xs,y,type="lasso",normalize=FALSE)
# get min BIC
# bic=log(n)*object$df+n*log(as.vector(object$RSS)/n) # rss/n version
sig2f=summary(out.ls)$sigma^2 # full model mse
bic2=log(n)*object$df+as.vector(object$RSS)/sig2f # Cp version
step.bic2=which.min(bic2) # step with min BIC
fit=predict.lars(object,xs,s=step.bic2,type="fit",mode="step")$fit
coeff=predict.lars(object,xs,s=step.bic2,type="coef",mode="step")$coefficients
coeff=coeff*w/normx # get back in right scale
st=sum(coeff !=0) # number nonzero
mse=sum((y-fit)^2)/(n-st-1) # 1 for the intercept
# this next line just finds the variable id of coeff. not equal 0
if(st>0) x.ind<-as.vector(which(coeff !=0)) else x.ind<-0
return(list(fit=fit,st=st,mse=mse,x.ind=x.ind,coeff=coeff,object=object,
bic2=bic2,step.bic2=step.bic2))
}
y <- log(data$count+1)
index <- data$index
numGenes <- length(unique(index))
data_back <- data[,-c(1,2)]
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options(contrasts=c("contr.sum","contr.poly"))
m <- lm(y~factor(index))
data_mean <- model.matrix(m)
data_total <- cbind(data_mean,data_back)
data_total <- data_total[-1]
position <- createPosition(numGenes, up, down)
geneMean <- rep(0,100)
for(i in 1:100)
{
geneMean[i] <- mean(y[data$index==i])
}
y_nomean <- (y - geneMean[data$index])
data_back_single <- data_total[,-c(1:99,343:1062)]
fit.lasso <- lasso.adapt.bic2(data_back_single,y_nomean,power,position)
aa <- fit.lasso$coef != 0
bb <- c(fit.lasso$coef[-c(1)] != 0, FALSE)
cc <- c(fit.lasso$coef[-c(12)] != 0, FALSE, FALSE)
dd <- rep(0, length(aa))
for(i in 1:length(aa))
{
dd[i] <- aa[i]+bb[i]+cc[i]
}
dd <- dd == 3
f <- min((which(dd==1)+2)[which((which(dd==1)+2) %% 3 ==0 )]-2)
g <- max((which(dd==1)+2)[which((which(dd==1)+2) %% 3 ==0 )])
ff <- 3*(up+down)+3*(f-1)+1
gg <- 3*(up+down)+9*((g/3)-1)
lengthUP <- 40-(f-1)/3
lengthDOWN <- (g/3)-41
seqLen <- lengthUP + lengthDOWN
f <- f+99
g <- g+99
ff <- ff+99
gg <- gg+99
74
fit <- lm(y~.,data=data_total[c(1:99,f:g,ff:gg)])
fit0 <- lm(y~.,data=as.data.frame(data_mean[,-1]))
p1 <- predict.lm(fit,data_total[c(1:99,f:g,ff:gg)])
p0 <- predict.lm(fit0,as.data.frame(data_mean[,-1]))
r2 <- 1-(sum((y-p1)^2))/(sum((y-p0)^2))
logLik <- logLik(fit)
list(seqLen=seqLen,lengthUP=lengthUP,lengthDOWN=lengthDOWN,r2=r2,logLik=logLik)
}
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